Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.European Journal of Cancer (Oxford, England : 1990)|November 19, 2021
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysisAndrea Becerril-Gaitan, Bryan F Vaca-Cartagena, Ana S Ferrigno, et al.ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.Breast Cancer (Dove Medical Press)|June 3, 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal WomenValentino Martelli, Maria Maddalena Latocca, Tommaso Ruelle, et al.JCO Oncology Practice|June 24, 2020
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research ActivitiesFrancesca Poggio, Marco Tagliamento, Massimo Di Maio, et al.European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2023
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural MesotheliomaMarco Tagliamento, Massimo Di Maio, Jordi Remon, et al.Current Oncology Reports|October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung CancerGiuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.Pageof 9